Loading…
Reported covered position: Regional Staff Asst & Staff Asst, Sen. Moynihan ;LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: WILLIAMS AND JENSEN, PLLC
Access and pricing issues for plasma derived products; Orphan Drug Act and therapies for rare diseases. H.R. 1, One Big Beautiful Bill Act implementation, issues related to biopharmaceutical issues. Prescription drug pricing issues, particularly related to MFN. Medicare Part B provisions relating to home infusion of IVIG.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ZOETIS via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Issues related to general corporate taxation; and implementation of PL 119-21.
Monitor trade issues including those under section 301 of the Trade Act of 1974, USMCA. Trade issues and supply chain issues related to veterinary pharmaceuticals and active ingredients, including tariff actions under Section 232 of the Trade Act of 1962.
Source: Senate LDA
| THE VANGUARD GROUP, INC. |
| 33 |
| 2018–2026 |
| SECURITY TRADERS ASSOCIATION | 32 | 2018–2026 |
| VISA | 32 | 2018–2026 |
| FEDERATION OF EXCHANGE ACCOMODATORS, INC. | 31 | 2019–2026 |
| SOUTHWESTERN COMPANY | 31 | 2019–2026 |
| NORFOLK SOUTHERN CORPORATION | 29 | 2019–2026 |
| PLASMA PROTEIN THERAPEUTICS ASSOCIATION | 29 | 2019–2026 |
| JOSEPH ABBOUD MANUFACTURING CORP (FKA J.A. APPAREL CORP) | 28 | 2020–2026 |
| NATIONAL ASSN OF STATE TREASURERS (NAST) | 28 | 2019–2025 |
| ELI LILLY & COMPANY | 27 | 2020–2026 |
| FEDERAL HOME LOAN BANK OF CINCINNATI | 27 | 2018–2025 |
| NOVO NORDISK, INC. | 27 | 2020–2026 |
| Tom James Company | 27 | 2020–2026 |
| W DIAMOND GROUP CORPORATION | 27 | 2020–2026 |
| INDIVIOR INC. | 26 | 2018–2024 |
| NEW ENGLAND SHIRT CO | 26 | 2020–2026 |
| STANLEY BLACK & DECKER INC | 26 | 2020–2026 |
| SYNEOS HEALTH, INC. | 26 | 2020–2026 |
| US GUATEMALA BUSINESS COUNCIL | 26 | 2018–2024 |
| ELEVANCE HEALTH, INC. (FORMERLY REPORTED AS ANTHEM, INC.) | 25 | 2018–2024 |
| AMGEN, INC. | 24 | 2021–2026 |
| Buhler Quality Yarns Corporation | 24 | 2020–2026 |
| OWENS & MINOR, INC. | 24 | 2021–2026 |
| PFIZER | 22 | 2021–2026 |
| BLOOMBERG LP | 21 | 2021–2026 |
| RIPPLE LABS, INC. | 21 | 2019–2024 |
| ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) | 20 | 2018–2023 |
| FIDELITY NATIONAL FINANCIAL | 18 | 2022–2026 |
| HAMILTON SHIRTS, LTD. | 18 | 2022–2026 |
| IMPERATIVE EXECUTION, INC. | 18 | 2022–2026 |
| MAUS & HOFFMAN | 18 | 2022–2026 |
| BIOBOT ANALYTICS | 17 | 2019–2023 |
| NATIONAL ASSOCIATION OF REHABILITATION PROVIDERS AND AGENCIES | 17 | 2019–2023 |
| SUPIMA | 17 | 2022–2026 |
| ZOETIS | 17 | 2022–2026 |
| KANSAS STATE UNIVERSITY | 15 | 2019–2022 |
| EXIGER | 14 | 2022–2025 |
| HICKEY FREEMAN TAILORED CLOTHING, INC | 14 | 2020–2023 |
| ROCHESTER TAILORED CLOTHING, INC. | 14 | 2023–2026 |
| IRHYTHM TECHNOLOGIES | 13 | 2021–2024 |
| AMERICAN AIRLINES, INC. | 12 | 2024–2026 |
| HARDWICK CLOTHES | 12 | 2020–2022 |
| AFFORDABLE HOUSING TAX CREDIT COALITION | 10 | 2024–2026 |
| FIBER INDUSTRIES LLC (DBA DARLING FIBERS) | 10 | 2021–2023 |
| MUNICIPAL SECURITIES RULEMAKING BOARD | 10 | 2019–2021 |
| TD AMERITRADE | 10 | 2018–2020 |
| CLARK STREET ASSOCIATES ON BEHALF OF ARRIS COMPOSITES | 9 | 2020–2021 |
| ENCOVA INSURANCE | 9 | 2020–2021 |
| FORD MOTOR COMPANY | 9 | 2024–2026 |
| I SQUARED CAPITAL ADVISORS (US) LLC | 9 | 2024–2026 |
| ALORICA, INC. | 8 | 2020–2021 |
| CENTENE CORPORATION | 8 | 2025–2026 |
| GCOM SOFTWARE LLC D/B/A VOYATEK | 8 | 2025–2026 |
| GENERAL ELECTRIC COMPANY (PREVIOUSLY REPORTED AS GE AVIATION) | 8 | 2019–2020 |
| IOWA CONFLUENCE WATER TRAILS (FORMERLY CENTRAL IOWA WATER TRAILS) | 8 | 2020–2021 |
| SKYTOP STRATEGIES | 8 | 2020–2022 |
| CUBE YADKIN GENERATION, LLC | 7 | 2023–2024 |
| GENENTECH INC | 7 | 2019–2020 |
| VEEAM SOFTWARE CORP | 7 | 2025–2026 |
| AMERICAN WAGERING INC DBA WILLIAM HILL US (DBA AMERICAN WAGING INC DBA WILLIA) | 6 | 2018–2019 |
| MITRA FUTURE TECHNOLOGIES, INC. | 6 | 2025–2026 |
| VERITEC SOLUTIONS, LLC | 6 | 2019–2020 |
| ABBVIE, INC. | 5 | 2026 |
| TAKEDA PHARMACEUTICALS AMERICA INC | 5 | 2020–2021 |
| US AGAINST ALZHEIMER'S | 5 | 2020–2021 |
| CLARK STREET ASSOCIATES ON BEHALF OF FUNGIBLE INC. | 4 | 2021 |
| COLORADO NONPROFIT DEVELOPMENT CENTER ON BEHALF OF ONE CHANCE TO GROW UP | 4 | 2022 |
| CUBE HYDRO PARTNERS | 4 | 2019–2020 |
| LIFESCIENCE LOGISTICS | 4 | 2022–2023 |
| BRISTOL-MYERS SQUIBB COMPANY | 3 | 2026 |
| BROOKS BROTHERS | 3 | 2020 |
| COLONIAL PIPELINE | 3 | 2021 |
| DISCOVERY COMMUNICATIONS, INC. | 3 | 2021 |
| GITMAN AND COMPANY | 3 | 2020 |
| POARCH BAND OF CREEK INDIANS | 3 | 2025 |
| PROPERTY CASUALTY INSURERS ASSOCIATION OF AMERICA | 3 | 2018–2019 |
| SOUTHWICK CLOTHING, LLC. | 3 | 2020 |
| CLARK STREET ASSOCIATES ON BEHALF OF WESTERN DIGITAL | 2 | 2020 |
| FINANCIAL OVERSIGHT AND MANAGEMENT BOARD FOR PUERTO RICO | 2 | 2018–2019 |
| INTERNATIONAL BOTTLED WATER ASSOCIATION | 2 | 2026 |
| OWENS-ILLINOIS INC | 2 | 2018 |
| THE PARTNERSHIP FOR A NEW AMERICAN ECONOMY ACTION FUND C/0 GELLER & COMPANY | 2 | 2019–2020 |
| U.S. HEMP ROUNDTABLE | 2 | 2026 |
| COSETTE PHARMACEUTICALS | 1 | 2026 |
| UNISON SOFTWARE, INC. | 1 | 2025 |
Medicare payment issues and Medicaid issues. Medicare Part D. Drug pricing proposals. Protecting Seniors Through Immunization Act. Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN. P.L. 119-21.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: WILLIAMS AND JENSEN, PLLC
Access and pricing issues for plasma derived products; Orphan Drug Act and therapies for rare diseases. H.R. 1, One Big Beautiful Bill Act implementation, issues related to biopharmaceutical issues. Prescription drug pricing issues, particularly related to MFN. Medicare Part B provisions relating to home infusion of IVIG.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMGEN, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Medicare Part D and Medicare Part B drug reimbursement, policies around MFN drug pricing, Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act" implementation, coverage and access for biosimilars.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Medicare payment issues and Medicaid issues. Medicare Part D. Drug pricing proposals. Protecting Seniors Through Immunization Act. Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN. P.L. 119-21.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: WILLIAMS AND JENSEN, PLLC
Access and pricing issues for plasma derived products; Orphan Drug Act and therapies for rare diseases. H.R. 1, One Big Beautiful Bill Act implementation, issues related to biopharmaceutical issues. Prescription drug pricing issues, particularly related to MFN. Medicare Part B provisions relating to home infusion of IVIG.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMGEN, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Medicare Part D and Medicare Part B drug reimbursement, policies around MFN drug pricing, Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act" implementation, coverage and access for biosimilars.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMGEN, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Medicare Part D and Medicare Part B drug reimbursement, policies around MFN drug pricing, Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act" implementation, coverage and access for biosimilars.
Mutual fund, ETF, money market mutual fund, securities, and systemic risk issues. H.R. 1033, Retirement Fairness for Charities and Educational Institutions Act of 2025; S.424, Retirement Fairness for Charities and Educational Institutions Act of 2025. H.R. 2441, Improving Disclosure for Investors Act of 2025; HR 3383, Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025; issues related to index funds; issues related to fund proxy voting; issues related to access to investment opportunities; issues related to products and markets. H.R. 3682, Financial Stability Oversight Council Improvement Act of 2025.
Mutual fund, ETF, money market mutual fund, securities, and systemic risk issues. H.R. 1033, Retirement Fairness for Charities and Educational Institutions Act of 2025; S.424, Retirement Fairness for Charities and Educational Institutions Act of 2025. H.R. 2441, Improving Disclosure for Investors Act of 2025; HR 3383, Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025; issues related to index funds; issues related to fund proxy voting; issues related to access to investment opportunities; issues related to products and markets. H.R. 3682, Financial Stability Oversight Council Improvement Act of 2025.
Mutual fund, ETF, money market mutual fund, securities, and systemic risk issues. H.R. 1033, Retirement Fairness for Charities and Educational Institutions Act of 2025; S.424, Retirement Fairness for Charities and Educational Institutions Act of 2025. H.R. 2441, Improving Disclosure for Investors Act of 2025; HR 3383, Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025; issues related to index funds; issues related to access to investment opportunities; issues related to products and markets. H.R. 3682, Financial Stability Oversight Council Improvement Act of 2025.
DMEPOS Relief Act of 2025
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
DMEPOS Relief Act of 2025
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to access to home medical equipment and related reimbursement (i.e., the "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4307) and the "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, the "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels. Issues related to continuous glucose monitors.
DMEPOS Relief Act of 2025
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Recycling Infrastructure and Accessibility Act of 2025
Client: INTERNATIONAL BOTTLED WATER ASSOCIATION · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 2145 - Recycling Infrastructure and Accessibility Act (RIAA).
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. H.R. 2353. Fiscal Year 2026 Homeland Security Appropriations.
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. H.R. 2353. Fiscal Year 2026 Homeland Security Appropriations.
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. H.R. 2353. P.L. 119-37; aviation issues impacted by government shutdown.
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. H.R. 2353. P.L. 119-37; aviation issues impacted by government shutdown.
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. H.R. 2353. P.L. 119-37; aviation issues impacted by government shutdown.
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. H.R. 2353. Fiscal Year 2026 Homeland Security Appropriations.
Improving Disclosure for Investors Act of 2025
Client: THE VANGUARD GROUP, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Mutual fund, ETF, money market mutual fund, securities, and systemic risk issues. H.R. 1033, Retirement Fairness for Charities and Educational Institutions Act of 2025; S.424, Retirement Fairness for Charities and Educational Institutions Act of 2025. H.R. 2441, Improving Disclosure for Investors Act of 2025; HR 3383, Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025; issues related to index funds; issues related to fund proxy voting; issues related to access to investment opportunities; issues related to products and markets. H.R. 3682, Financial Stability Oversight Council Improvement Act of 2025.
Improving Disclosure for Investors Act of 2025
Client: THE VANGUARD GROUP, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Mutual fund, ETF, money market mutual fund, securities, and systemic risk issues. H.R. 1033, Retirement Fairness for Charities and Educational Institutions Act of 2025; S.424, Retirement Fairness for Charities and Educational Institutions Act of 2025. H.R. 2441, Improving Disclosure for Investors Act of 2025; HR 3383, Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025; issues related to index funds; issues related to fund proxy voting; issues related to access to investment opportunities; issues related to products and markets. H.R. 3682, Financial Stability Oversight Council Improvement Act of 2025.
Improving Disclosure for Investors Act of 2025
Client: THE VANGUARD GROUP, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Mutual fund, ETF, money market mutual fund, securities, and systemic risk issues. H.R. 1033, Retirement Fairness for Charities and Educational Institutions Act of 2025; S.424, Retirement Fairness for Charities and Educational Institutions Act of 2025. H.R. 2441, Improving Disclosure for Investors Act of 2025; HR 3383, Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025; issues related to index funds; issues related to access to investment opportunities; issues related to products and markets. H.R. 3682, Financial Stability Oversight Council Improvement Act of 2025.
Affordable Housing Credit Improvement Act of 2025
Client: AFFORDABLE HOUSING TAX CREDIT COALITION · Firm: WILLIAMS AND JENSEN, PLLC
Implementation of PL 119-21; proposals to strengthen and expand the Low-Income Housing Tax Credit and Tax-Exempt Housing Bonds. Affordable Housing Credit Improvement Act. Affordable Housing Credit Improvement Act of 2025, H.R. 2725, S. 1515.
Affordable Housing Credit Improvement Act of 2025
Client: AFFORDABLE HOUSING TAX CREDIT COALITION · Firm: WILLIAMS AND JENSEN, PLLC
Implementation of PL 119-21; proposals to strengthen and expand the Low-Income Housing Tax Credit and Tax-Exempt Housing Bonds. Affordable Housing Credit Improvement Act. Affordable Housing Credit Improvement Act of 2025, H.R. 2725, S. 1515. H.R.9012.
Affordable Housing Credit Improvement Act of 2025
Client: AFFORDABLE HOUSING TAX CREDIT COALITION · Firm: WILLIAMS AND JENSEN, PLLC
Implementation of PL 119-21; proposals to strengthen and expand the Low-Income Housing Tax Credit and Tax-Exempt Housing Bonds. Affordable Housing Credit Improvement Act. Affordable Housing Credit Improvement Act of 2025, H.R. 2725, S. 1515.
SOAR Act of 2025
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to access to home medical equipment and related reimbursement (i.e., the "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4307) and the "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, the "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels. Issues related to continuous glucose monitors.
SOAR Act of 2025
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
SOAR Act of 2025
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Protecting America's Property Rights Act
Client: FIDELITY NATIONAL FINANCIAL · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to title insurance, HR 3206 Protecting America's Property Rights Act.
Protecting America's Property Rights Act
Client: FIDELITY NATIONAL FINANCIAL · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to title insurance, HR 3206 Protecting America's Property Rights Act.
Protecting America's Property Rights Act
Client: FIDELITY NATIONAL FINANCIAL · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 3206, Protecting Americas Property Rights Act.
Protecting America's Property Rights Act
Client: FIDELITY NATIONAL FINANCIAL · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to title insurance, HR 3206 Protecting America's Property Rights Act.
Protecting America's Property Rights Act
Client: FIDELITY NATIONAL FINANCIAL · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 3206, Protecting Americas Property Rights Act.
Protecting America's Property Rights Act
Client: FIDELITY NATIONAL FINANCIAL · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 3206, Protecting Americas Property Rights Act.
Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025
Client: THE VANGUARD GROUP, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Mutual fund, ETF, money market mutual fund, securities, and systemic risk issues. H.R. 1033, Retirement Fairness for Charities and Educational Institutions Act of 2025; S.424, Retirement Fairness for Charities and Educational Institutions Act of 2025. H.R. 2441, Improving Disclosure for Investors Act of 2025; HR 3383, Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025; issues related to index funds; issues related to fund proxy voting; issues related to access to investment opportunities; issues related to products and markets. H.R. 3682, Financial Stability Oversight Council Improvement Act of 2025.
Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025
Client: SECURITY TRADERS ASSOCIATION · Firm: WILLIAMS AND JENSEN, PLLC
Equity market structure, trading, and listing and delisting issues. H.R. 3383, INVEST Act of 2025; securities fraud prevention; Section 31 transaction fees.
Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025
Client: SECURITY TRADERS ASSOCIATION · Firm: WILLIAMS AND JENSEN, PLLC
Equity market structure, trading, and listing and delisting issues. H.R. 3383, INVEST Act of 2025; securities fraud prevention; Section 31 transaction fees.
Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025
Client: SECURITY TRADERS ASSOCIATION · Firm: WILLIAMS AND JENSEN, PLLC
Equity market structure, trading, and listing and delisting issues. H.R. 3383, INVEST Act of 2025; securities fraud prevention; Section 31 transaction fees.
Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025
Client: THE VANGUARD GROUP, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Mutual fund, ETF, money market mutual fund, securities, and systemic risk issues. H.R. 1033, Retirement Fairness for Charities and Educational Institutions Act of 2025; S.424, Retirement Fairness for Charities and Educational Institutions Act of 2025. H.R. 2441, Improving Disclosure for Investors Act of 2025; HR 3383, Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025; issues related to index funds; issues related to access to investment opportunities; issues related to products and markets. H.R. 3682, Financial Stability Oversight Council Improvement Act of 2025.
Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025
Client: THE VANGUARD GROUP, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Mutual fund, ETF, money market mutual fund, securities, and systemic risk issues. H.R. 1033, Retirement Fairness for Charities and Educational Institutions Act of 2025; S.424, Retirement Fairness for Charities and Educational Institutions Act of 2025. H.R. 2441, Improving Disclosure for Investors Act of 2025; HR 3383, Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025; issues related to index funds; issues related to fund proxy voting; issues related to access to investment opportunities; issues related to products and markets. H.R. 3682, Financial Stability Oversight Council Improvement Act of 2025.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act. H.R. 6644 21st Century Road to Housing Act.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 / S.1582 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act. P.L. 119-60. 21st Century Road to Housing Act.
Issues relating to investor access to financial identifiers (including implementation of the Financial Data Transparency Act) and market structure. HR3633, CLARITY Act, tokenization.
Issues relating to investor access to financial identifiers (including implementation of the Financial Data Transparency Act) and market structure. HR3633, CLARITY Act, tokenization.
Financial Stability Oversight Council Improvement Act of 2025
Client: THE VANGUARD GROUP, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Mutual fund, ETF, money market mutual fund, securities, and systemic risk issues. H.R. 1033, Retirement Fairness for Charities and Educational Institutions Act of 2025; S.424, Retirement Fairness for Charities and Educational Institutions Act of 2025. H.R. 2441, Improving Disclosure for Investors Act of 2025; HR 3383, Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025; issues related to index funds; issues related to fund proxy voting; issues related to access to investment opportunities; issues related to products and markets. H.R. 3682, Financial Stability Oversight Council Improvement Act of 2025.
Financial Stability Oversight Council Improvement Act of 2025
Client: THE VANGUARD GROUP, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Mutual fund, ETF, money market mutual fund, securities, and systemic risk issues. H.R. 1033, Retirement Fairness for Charities and Educational Institutions Act of 2025; S.424, Retirement Fairness for Charities and Educational Institutions Act of 2025. H.R. 2441, Improving Disclosure for Investors Act of 2025; HR 3383, Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025; issues related to index funds; issues related to access to investment opportunities; issues related to products and markets. H.R. 3682, Financial Stability Oversight Council Improvement Act of 2025.
Financial Stability Oversight Council Improvement Act of 2025
Client: THE VANGUARD GROUP, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Mutual fund, ETF, money market mutual fund, securities, and systemic risk issues. H.R. 1033, Retirement Fairness for Charities and Educational Institutions Act of 2025; S.424, Retirement Fairness for Charities and Educational Institutions Act of 2025. H.R. 2441, Improving Disclosure for Investors Act of 2025; HR 3383, Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025; issues related to index funds; issues related to fund proxy voting; issues related to access to investment opportunities; issues related to products and markets. H.R. 3682, Financial Stability Oversight Council Improvement Act of 2025.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: ABBVIE, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Drug pricing policies, implementation of IRA drug pricing policies, access and coverage, most-favored nation drug pricing policies, ORPHAN Cures Act implementation. H.R.4299 - Protecting Patient Access to Cancer and Complex Therapies Act.
H.R. 643 - Federal Insurance Office Elimination Act. Federal Insurance Office legislation. S.2349, INSURE Act; H.R. 4504, INSURE Act. Legislation to create a federal property insurance or reinsurance program. International insurance legislation. Terrorism Risk Insurance legislation. H.R. 7128, TRIA Program Reauthorization Act of 2026; S.4395, Terrorism Risk Insurance Program Reauthorization Act of 2026.
H.R. 643 - Federal Insurance Office Elimination Act. Federal Insurance Office legislation. S.2349, INSURE Act; H.R. 4504, INSURE Act. Legislation to create a federal property insurance or reinsurance program. International insurance legislation. Terrorism Risk Insurance legislation.
H.R. 643 - Federal Insurance Office Elimination Act. Federal Insurance Office legislation. S.2349, INSURE Act; H.R. 4504, INSURE Act. Legislation to create a federal property insurance or reinsurance program. International insurance legislation. Terrorism Risk Insurance legislation. H.R. 7128, TRIA Program Reauthorization Act of 2026; S.4395, Terrorism Risk Insurance Program Reauthorization Act of 2026.
Community Investment and Prosperity Act
Client: AFFORDABLE HOUSING TAX CREDIT COALITION · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to low-income housing finance; S. 2296, S. 1071, H.R. 6644; S. 2464; H.R. 5913 - Community Investment and Prosperity Act. 21st Century Road to Housing Act; build to rent housing proposals.
Community Investment and Prosperity Act
Client: AFFORDABLE HOUSING TAX CREDIT COALITION · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to low-income housing finance; S. 2296, S. 1071, H.R. 6644; S. 2464; H.R. 5913 - Community Investment and Prosperity Act. 21st Century ROAD to Housing Act; build to rent housing proposals.
Community Investment and Prosperity Act
Client: AFFORDABLE HOUSING TAX CREDIT COALITION · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to low-income housing finance; S. 2296, S. 1071, H.R. 6644; S. 2464; H.R. 5913 - Community Investment and Prosperity Act. 21st Century ROAD to Housing Act; build to rent housing proposals. Issues related to proposed Basel III changes; revised regulations under the Community Reinvestment Act.
340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies. SAFE Drugs Act (HR6509/S3794). FDA actions on drug compounding and illicit drugs. Issues related to TrumpRX. Alzheimer's Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267).
Federal Insurance Office Elimination Act
Client: REINSURANCE ASSOCIATION OF AMERICA · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 643 - Federal Insurance Office Elimination Act. Federal Insurance Office legislation. S.2349, INSURE Act; H.R. 4504, INSURE Act. Legislation to create a federal property insurance or reinsurance program. International insurance legislation. Terrorism Risk Insurance legislation. H.R. 7128, TRIA Program Reauthorization Act of 2026; S.4395, Terrorism Risk Insurance Program Reauthorization Act of 2026.
Federal Insurance Office Elimination Act
Client: REINSURANCE ASSOCIATION OF AMERICA · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 643 - Federal Insurance Office Elimination Act. Federal Insurance Office legislation. S.2349, INSURE Act; H.R. 4504, INSURE Act. Legislation to create a federal property insurance or reinsurance program. International insurance legislation. Terrorism Risk Insurance legislation.
Federal Insurance Office Elimination Act
Client: REINSURANCE ASSOCIATION OF AMERICA · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 643 - Federal Insurance Office Elimination Act. Federal Insurance Office legislation. S.2349, INSURE Act; H.R. 4504, INSURE Act. Legislation to create a federal property insurance or reinsurance program. International insurance legislation. Terrorism Risk Insurance legislation. H.R. 7128, TRIA Program Reauthorization Act of 2026; S.4395, Terrorism Risk Insurance Program Reauthorization Act of 2026.
340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies. SAFE Drugs Act (HR6509/S3794).
Medication affordability and access; general diabetes prevention, 340B, monitoring FDA reform, changes and new programs. SAFE Drugs Act (HR6509/S3794).
Medication affordability and access; general diabetes prevention, 340B, monitoring FDA reform, changes and new programs. SAFE Drugs Act (HR6509/S3794). FDA actions on drug compounding and illicit drugs. Issues related to TrumpRX.
340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies. SAFE Drugs Act (HR6509/S3794). FDA actions on drug compounding and illicit drugs. Issues related to TrumpRX. Alzheimer's Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267).
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act. H.R. 6644 21st Century Road to Housing Act.
21st Century ROAD to Housing Act
Client: AFFORDABLE HOUSING TAX CREDIT COALITION · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to low-income housing finance; S. 2296, S. 1071, H.R. 6644; S. 2464; H.R. 5913 - Community Investment and Prosperity Act. 21st Century ROAD to Housing Act; build to rent housing proposals. Issues related to proposed Basel III changes; revised regulations under the Community Reinvestment Act.
21st Century ROAD to Housing Act
Client: AFFORDABLE HOUSING TAX CREDIT COALITION · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to low-income housing finance; S. 2296, S. 1071, H.R. 6644; S. 2464; H.R. 5913 - Community Investment and Prosperity Act. 21st Century ROAD to Housing Act; build to rent housing proposals.
21st Century ROAD to Housing Act
Client: AFFORDABLE HOUSING TAX CREDIT COALITION · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to low-income housing finance; S. 2296, S. 1071, H.R. 6644; S. 2464; H.R. 5913 - Community Investment and Prosperity Act. 21st Century Road to Housing Act; build to rent housing proposals.
Hemp Planting Predictability Act
Client: U.S. HEMP ROUNDTABLE · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to regulation of Hemp products. H.R. 7024, Hemp Planting Predictability Act.
Hemp Planting Predictability Act
Client: U.S. HEMP ROUNDTABLE · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to regulation of Hemp products. H.R. 7024, Hemp Planting Predictability Act.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act. H.R. 6644 21st Century Road to Housing Act.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 / S.1582 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act. P.L. 119-60. 21st Century Road to Housing Act.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act.
TRIA Program Reauthorization Act of 2026
Client: REINSURANCE ASSOCIATION OF AMERICA · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 643 - Federal Insurance Office Elimination Act. Federal Insurance Office legislation. S.2349, INSURE Act; H.R. 4504, INSURE Act. Legislation to create a federal property insurance or reinsurance program. International insurance legislation. Terrorism Risk Insurance legislation. H.R. 7128, TRIA Program Reauthorization Act of 2026; S.4395, Terrorism Risk Insurance Program Reauthorization Act of 2026.
TRIA Program Reauthorization Act of 2026
Client: REINSURANCE ASSOCIATION OF AMERICA · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 643 - Federal Insurance Office Elimination Act. Federal Insurance Office legislation. S.2349, INSURE Act; H.R. 4504, INSURE Act. Legislation to create a federal property insurance or reinsurance program. International insurance legislation. Terrorism Risk Insurance legislation. H.R. 7128, TRIA Program Reauthorization Act of 2026; S.4395, Terrorism Risk Insurance Program Reauthorization Act of 2026.
Hemp Enforcement, Modernization, and Protection Act
Client: U.S. HEMP ROUNDTABLE · Firm: WILLIAMS AND JENSEN, PLLC
HR 7212 To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of cannabinoid hemp products, and for other purposes.
Hemp Enforcement, Modernization, and Protection Act
Client: U.S. HEMP ROUNDTABLE · Firm: WILLIAMS AND JENSEN, PLLC
HR 7212 To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of cannabinoid hemp products, and for other purposes. H.R.9830 - Lawful Hemp Protection Act.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027
Client: REINSURANCE ASSOCIATION OF AMERICA · Firm: WILLIAMS AND JENSEN, PLLC
Appropriations, pre-disaster mitigation, NFIP. Risk transfer legislation. H.R. 8845, Commerce, Justice, Science, and Related Agencies Appropriations bill, 2027, and S. ___ - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027. National Oceanic and Atmospheric Administration.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027
Client: REINSURANCE ASSOCIATION OF AMERICA · Firm: WILLIAMS AND JENSEN, PLLC
Appropriations, pre-disaster mitigation, NFIP. Risk transfer legislation. H.R. 8845, Commerce, Justice, Science, and Related Agencies Appropriations bill, 2027, and S. ___ - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027. National Oceanic and Atmospheric Administration.
DME Scammer Prevention Act of 2026
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
DME Scammer Prevention Act of 2026
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Affordable Housing Credit Carryback Act
Client: AFFORDABLE HOUSING TAX CREDIT COALITION · Firm: WILLIAMS AND JENSEN, PLLC
Implementation of PL 119-21; proposals to strengthen and expand the Low-Income Housing Tax Credit and Tax-Exempt Housing Bonds. Affordable Housing Credit Improvement Act. Affordable Housing Credit Improvement Act of 2025, H.R. 2725, S. 1515. H.R.9012.
HR 7212 To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of cannabinoid hemp products, and for other purposes. H.R.9830 - Lawful Hemp Protection Act.
Digital news content and publishing; antitrust issues impacting digital news publishers. Artificial Intelligence policies. Stealth Bot Prohibition Act (H.R. 9915).
National Defense Authorization Act for Fiscal Year 2026
Client: AFFORDABLE HOUSING TAX CREDIT COALITION · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to low-income housing finance; S. 2296, S. 1071, H.R. 6644; S. 2464; H.R. 5913 - Community Investment and Prosperity Act. 21st Century Road to Housing Act; build to rent housing proposals.
National Defense Authorization Act for Fiscal Year 2026
Client: AFFORDABLE HOUSING TAX CREDIT COALITION · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to low-income housing finance; S. 2296, S. 1071, H.R. 6644; S. 2464; H.R. 5913 - Community Investment and Prosperity Act. 21st Century ROAD to Housing Act; build to rent housing proposals. Issues related to proposed Basel III changes; revised regulations under the Community Reinvestment Act.
National Defense Authorization Act for Fiscal Year 2026
Client: AFFORDABLE HOUSING TAX CREDIT COALITION · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to low-income housing finance; S. 2296, S. 1071, H.R. 6644; S. 2464; H.R. 5913 - Community Investment and Prosperity Act. 21st Century ROAD to Housing Act; build to rent housing proposals.
SOAR Act of 2025
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to access to home medical equipment and related reimbursement (i.e., the "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4307) and the "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, the "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels. Issues related to continuous glucose monitors.
SOAR Act of 2025
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
SOAR Act of 2025
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Affordable Housing Credit Improvement Act of 2025
Client: AFFORDABLE HOUSING TAX CREDIT COALITION · Firm: WILLIAMS AND JENSEN, PLLC
Implementation of PL 119-21; proposals to strengthen and expand the Low-Income Housing Tax Credit and Tax-Exempt Housing Bonds. Affordable Housing Credit Improvement Act. Affordable Housing Credit Improvement Act of 2025, H.R. 2725, S. 1515. H.R.9012.
Affordable Housing Credit Improvement Act of 2025
Client: AFFORDABLE HOUSING TAX CREDIT COALITION · Firm: WILLIAMS AND JENSEN, PLLC
Implementation of PL 119-21; proposals to strengthen and expand the Low-Income Housing Tax Credit and Tax-Exempt Housing Bonds. Affordable Housing Credit Improvement Act. Affordable Housing Credit Improvement Act of 2025, H.R. 2725, S. 1515.
Affordable Housing Credit Improvement Act of 2025
Client: AFFORDABLE HOUSING TAX CREDIT COALITION · Firm: WILLIAMS AND JENSEN, PLLC
Implementation of PL 119-21; proposals to strengthen and expand the Low-Income Housing Tax Credit and Tax-Exempt Housing Bonds. Affordable Housing Credit Improvement Act. Affordable Housing Credit Improvement Act of 2025, H.R. 2725, S. 1515.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. S. 1582.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 / S.1582 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act. P.L. 119-60. 21st Century Road to Housing Act.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. S. 1582.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. S. 1582.
National Defense Authorization Act for Fiscal Year 2026
Client: AFFORDABLE HOUSING TAX CREDIT COALITION · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to low-income housing finance; S. 2296, S. 1071, H.R. 6644; S. 2464; H.R. 5913 - Community Investment and Prosperity Act. 21st Century ROAD to Housing Act; build to rent housing proposals.
National Defense Authorization Act for Fiscal Year 2026
Client: AFFORDABLE HOUSING TAX CREDIT COALITION · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to low-income housing finance; S. 2296, S. 1071, H.R. 6644; S. 2464; H.R. 5913 - Community Investment and Prosperity Act. 21st Century ROAD to Housing Act; build to rent housing proposals. Issues related to proposed Basel III changes; revised regulations under the Community Reinvestment Act.
General agricultural issues important to livestock producers, animal health and related policy issues. Issues impacting medicines and vaccines for animals.
Animal health, issues impacting medicines and vaccines for animals.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
VISA via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Cybersecurity and information sharing and cyber threats.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI, U.S. via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. 340B, Vaccine issues. Issues related to TrumpRX.
Monitor general tax issues related to international tax, vaccine excise taxes and orphan drug tax issues; implementation of PL 119-21.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Medication affordability and access; general diabetes prevention, 340B, monitoring FDA reform, changes and new programs. SAFE Drugs Act (HR6509/S3794). FDA actions on drug compounding and illicit drugs. Issues related to TrumpRX.
Treat and Reduce Obesity Act; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169) implementation. Pharmacy benefit manager reform proposals. Issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.
Support for obesity drug coverage and access.
General issues related to patent protections.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SYNEOS HEALTH, INC. via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Business and corporate tax issues, international tax reform; issues related to research and development.
Remote clinical trials, biomedical research & development.
Clinical trials and research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Support for immunization access, access to migraine screening. Support for tick-borne disease research and womens health.
Issues related to pharmaceutical manufacturing and development. Issues related to China WRT the BINSA bill.
Tax issues affecting the pharmaceutical industry including international tax; implementation of PL 119-21. Vaccine excise tax issues and VICP.
ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · 3T
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
FY 2027 Appropriations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NEWS MEDIA ALLIANCE via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Digital news content and publishing; antitrust issues impacting digital news publishers. Artificial Intelligence policies.
Digital news content and publishing; antitrust issues impacting digital news publishers. Artificial Intelligence policies.
Digital news content and publishing; antitrust issues impacting digital news publishers. Artificial Intelligence policies.
MITRA FUTURE TECHNOLOGIES, INC. via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Advanced domestic manufacturing and battery supply chain issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL BOTTLED WATER ASSOCIATION via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
H.R. 2145 - Recycling Infrastructure and Accessibility Act (RIAA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FORD MOTOR COMPANY via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Monitor issues related to implementation of and guidance on energy and manufacturing provisions enacted in PL 119-21, and auto loan deduction.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY & COMPANY via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies. SAFE Drugs Act (HR6509/S3794). FDA actions on drug compounding and illicit drugs. Issues related to TrumpRX. Alzheimer's Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267).
Monitor Issues related to intellectual property protection and market access within current trade negotiations. Section 232 investigations and other tariff issues. Pharmaceutical IP issues, march-in rights. Issues related to China WRT the BINSA bill.
Issues related to pharmaceutical manufacturing and development. Issues related to China WRT the BINSA bill.
BRISTOL-MYERS SQUIBB COMPANY via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Monitoring 232 investigations, monitoring tariffs, most favored nation drug pricing policies, pharmaceutical IP issues. Issues related to China WRT the BINSA bill.
340B Reform, FDA drug approvals, monitoring Food is Medicine initiatives, importation of biopharmaceutical products, pharmaceutical supply chain. Issues related to TrumpRX.
H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act, monitoring efforts around direct-to-consumer policies.
AMERICAN AIRLINES, INC. via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. H.R. 2353. P.L. 119-37; aviation issues impacted by government shutdown.
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. H.R. 2353. Fiscal Year 2026 Homeland Security Appropriations.
ABBVIE, INC. via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Drug pricing policies, implementation of IRA drug pricing policies, access and coverage, most-favored nation drug pricing policies, ORPHAN Cures Act implementation. H.R.4299 - Protecting Patient Access to Cancer and Complex Therapies Act.
Issues related to China WRT the BINSA bill.
340B Reform, FDA drug approvals, monitoring Food is Medicine initiatives, importation of biopharmaceutical products, pharmaceutical supply chain. Prescription drug advertising issues. Issues related to TrumpRX.
VEEAM SOFTWARE CORP via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Cybersecurity issues related to data resilience and system backup and availability, and ensuring the integrity of artificial intelligence systems.
Cybersecurity and procurement issues related to data resilience and system backup and availability, and ensuring the integrity of artificial intelligence systems.
Cybersecurity issues related to data resilience and system backup and availability, and ensuring the integrity of artificial intelligence systems.
SOUTHWESTERN COMPANY via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Issues pertaining to J-Visa exchange visitor programs.
State Department Appropriations for international cultural exchange programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), White House Office
ROCHESTER TAILORED CLOTHING, INC. via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
MAUS & HOFFMAN via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Duties on cotton and wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
HAMILTON SHIRTS, LTD. via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
TOM JAMES COMPANY via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Duties on cotton and wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
SUPIMA via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
W DIAMOND GROUP CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
JOSEPH ABBOUD MANUFACTURING CORP (FKA J.A. APPAREL CORP) via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
CENTENE CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Issues related to Medicaid, Medicare Advantage, behavioral health and prior authorization.
Issues related to health insurance and affordability.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BUHLER QUALITY YARNS CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
NORFOLK SOUTHERN CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
General education about policies impacting the rail industry; outreach to House and Senate related to rail operations. Proposed merger between Norfolk Southern and Union Pacific.
General education about policies impacting the rail industry; outreach to House and Senate related to rail operations. Proposed merger between Norfolk Southern and Union Pacific.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AFFORDABLE HOUSING TAX CREDIT COALITION via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Issues related to low-income housing finance; S. 2296, S. 1071, H.R. 6644; S. 2464; H.R. 5913 - Community Investment and Prosperity Act. 21st Century ROAD to Housing Act; build to rent housing proposals. Issues related to proposed Basel III changes; revised regulations under the Community Reinvestment Act.
Implementation of PL 119-21; proposals to strengthen and expand the Low-Income Housing Tax Credit and Tax-Exempt Housing Bonds. Affordable Housing Credit Improvement Act. Affordable Housing Credit Improvement Act of 2025, H.R. 2725, S. 1515. H.R.9012.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Issues related to pharmaceutical tariffs and related trade agreements.
Matters related to access of plasma derived products, FDA drug approval and monitoring agency changes. Matters affecting plasma donation and potential plasma shortages. Pharmacy Benefit Manager reform.
Access and pricing issues for plasma derived products; Orphan Drug Act and therapies for rare diseases. H.R. 1, One Big Beautiful Bill Act implementation, issues related to biopharmaceutical issues. Prescription drug pricing issues, particularly related to MFN. Medicare Part B provisions relating to home infusion of IVIG.
AMGEN, INC. via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Medicare Part D and Medicare Part B drug reimbursement, policies around MFN drug pricing, Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act" implementation, coverage and access for biosimilars.
Policies impacting disease prevention.
General education about federal policies impacting pharmaceutical development, approval, and patient access. 340B, Policies impacting public health preparedness and prevention. Policies impacting Cardiovascular and bone health. Pharmacy benefit manager reform proposals. FDA reform, prescription drug reimportation and new proposals.
STANLEY BLACK & DECKER INC via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Imports, exports and foreign markets; general trade issues and related matters including duties and tariffs. Issues related to Foreign Trade Zones and manufacturing in the U.S. Section 232 of the Trade Expansion Act of 1962 and Section 301 of the Trade Act of 1974; actions, exemptions and exclusions.
Manufacturing issues, general; Issues related to workforce development, and increased training and education related to advanced manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE INTERNET & TELEVISION ASSN (FORMERLY NTL CABLE & TELECOMMUNICATIONS ASSN) via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Legislation affecting multichannel TV, broadband, telephone, and the Internet, including taxation, intellectual property, spectrum allocation and regulatory issues, state taxation of cable TV and DBS, open Internet/broadband industry practices, data privacy, children's privacy, and rural broadband policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMCAST CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Legislation affecting multichannel TV, broadband, telephone, and the Internet, including intellectual property, spectrum allocation, carriage and regulatory issues, broadband industry practices, data privacy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELL INC via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Information technology legislation; appropriations legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
COSETTE PHARMACEUTICALS via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
General education about estradiol patch supply and demand issues and discussions on FDA shortage evaluations.
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS), SENATE
THE VANGUARD GROUP, INC. via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Retirement and savings issues, generally. Monitor implementation of IRC sec. 530A.
General tax issues related to mutual funds. Taxation of long term investments. Taxation of RICs and ETFs; potential negative impacts on markets and customers of proposed withholding tax on dividend payments. Monitor implementation of IRC sec. 530A.
Mutual fund, ETF, money market mutual fund, securities, and systemic risk issues. H.R. 1033, Retirement Fairness for Charities and Educational Institutions Act of 2025; S.424, Retirement Fairness for Charities and Educational Institutions Act of 2025. H.R. 2441, Improving Disclosure for Investors Act of 2025; HR 3383, Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025; issues related to index funds; issues related to fund proxy voting; issues related to access to investment opportunities; issues related to products and markets. H.R. 3682, Financial Stability Oversight Council Improvement Act of 2025.
SECURITY TRADERS ASSOCIATION via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Equity market structure, trading, and listing and delisting issues. H.R. 3383, INVEST Act of 2025; securities fraud prevention; Section 31 transaction fees.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
IMPERATIVE EXECUTION, INC. via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
SEC and FINRA equity market structure issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
ABBVIE, INC. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · 2A
H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act, monitoring efforts around direct-to-consumer policies.
Monitoring 232 investigations, monitoring tariffs, most favored nation drug pricing policies, pharmaceutical IP issues.
340B Reform, FDA drug approvals, monitoring Food is Medicine initiatives, importation of biopharmaceutical products, pharmaceutical supply chain. Prescription drug advertising issues.
U.S. HEMP ROUNDTABLE via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Issues related to provisions in the annual appropriations process that regulate Hemp.
Issues related to regulation of Hemp products. H.R. 7024, Hemp Planting Predictability Act.
HR 7212 To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of cannabinoid hemp products, and for other purposes. H.R.9830 - Lawful Hemp Protection Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
REINSURANCE ASSOCIATION OF AMERICA via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
National Oceanic and Atmospheric Administration.
National Flood Insurance Act legislation.
Appropriations, pre-disaster mitigation, NFIP. Risk transfer legislation. H.R. 8845, Commerce, Justice, Science, and Related Agencies Appropriations bill, 2027, and S. ___ - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027. National Oceanic and Atmospheric Administration.
FIDELITY NATIONAL FINANCIAL via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Issues related to title insurance, HR 3206 Protecting America's Property Rights Act.
H.R. 3206, Protecting Americas Property Rights Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
FEDERATION OF EXCHANGE ACCOMODATORS, INC. via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Monitor any possible change to IRC 1031 including any impact on qualified intermediaries. Monitor all IRC 1031 tax regulatory issues, and any proposed regulation of qualified intermediaries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
BLOOMBERG LP via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · Q3
Issues relating to investor access to financial identifiers (including implementation of the Financial Data Transparency Act) and market structure. HR3633, CLARITY Act, tokenization.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL BOTTLED WATER ASSOCIATION via WILLIAMS AND JENSEN, PLLC
2026 · third_quarter · RR
Issues affecting the bottled water industry and water infrastructure.
DELL INC via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Information technology legislation; appropriations legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
ZOETIS via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
General agricultural issues important to livestock producers, animal health and related policy issues. Issues impacting medicines and vaccines for animals.
Monitor trade issues including those under section 301 of the Trade Act of 1974, USMCA. Monitor trade issues and supply chain issues related to veterinary pharmaceuticals and active ingredients. Potential tariff actions under Section 232 of the Trade Act of 1962.
Animal health, issues impacting medicines and vaccines for animals.
VISA via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act. H.R. 6644 21st Century Road to Housing Act.
Cybersecurity and information sharing and cyber threats.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI, U.S. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. 340B, Vaccine issues.
Monitor general tax issues related to international tax, vaccine excise taxes and orphan drug tax issues; implementation of PL 119-21.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Treat and Reduce Obesity Act; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169) implementation. Pharmacy benefit manager reform proposals. H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.
Support for obesity drug coverage and access.
General issues related to patent protections.
SYNEOS HEALTH, INC. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Business and corporate tax issues, international tax reform; issues related to research and development.
Clinical trials and research.
Remote clinical trials, biomedical research & development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Medicare payment issues and Medicaid issues. Medicare Part D. Drug pricing proposals. Protecting Seniors Through Immunization Act. Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN. P.L. 119-21.
Issues related to pharmaceutical manufacturing and development, trade and tariffs; potential tariff actions under Section 232 of the Trade Act of 1962.
General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; drug importation; and drug shortages. Drug pricing proposals. The 340B program. Pharmacy benefit manager reform proposals, issues related to headache and migraine. P.L. 119-21.
ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
FY 2027 Appropriations.
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NEWS MEDIA ALLIANCE via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Digital news content and publishing; antitrust issues impacting digital news publishers. Artificial Intelligence policies.
Digital news content and publishing; antitrust issues impacting digital news publishers. Artificial Intelligence policies.
Digital news content and publishing; antitrust issues impacting digital news publishers. Artificial Intelligence policies.
MITRA FUTURE TECHNOLOGIES, INC. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Advanced domestic manufacturing and battery supply chain issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FORD MOTOR COMPANY via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Monitor issues related to implementation of and guidance on energy and manufacturing provisions enacted in PL 119-21, and auto loan deduction.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY & COMPANY via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Accelerated approval pathway; support for Alzheimer's diagnostics; obesity treatment.
Issues related to pharmaceutical manufacturing and development.
Monitor Issues related to intellectual property protection and market access within current trade negotiations. Section 232 investigations and other tariff issues. Pharmaceutical IP issues, march-in rights.
BRISTOL-MYERS SQUIBB COMPANY via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Monitoring 232 investigations, monitoring tariffs, most favored nation drug pricing policies, pharmaceutical IP issues.
Drug pricing policies, implementation of IRA drug pricing policies, access and coverage, most-favored nation drug pricing policies, ORPHAN Cures Act implementation.
H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act, monitoring efforts around direct-to-consumer policies.
AMERICAN AIRLINES, INC. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. S. 1582.
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. H.R. 2353. Fiscal Year 2026 Homeland Security Appropriations.
ABBVIE, INC. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Drug pricing policies, implementation of IRA drug pricing policies, access and coverage, most-favored nation drug pricing policies, ORPHAN Cures Act implementation.
340B Reform, FDA drug approvals, monitoring Food is Medicine initiatives, importation of biopharmaceutical products, pharmaceutical supply chain. Prescription drug advertising issues.
Monitoring 232 investigations, monitoring tariffs, most favored nation drug pricing policies, pharmaceutical IP issues.
THE INTERNET & TELEVISION ASSN (FORMERLY NTL CABLE & TELECOMMUNICATIONS ASSN) via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Legislation affecting multichannel TV, broadband, telephone, and the Internet, including taxation, intellectual property, spectrum allocation and regulatory issues, state taxation of cable TV and DBS, open Internet/broadband industry practices, data privacy, children's privacy, and rural broadband policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMCAST CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Legislation affecting multichannel TV, broadband, telephone, and the Internet, including intellectual property, spectrum allocation, carriage and regulatory issues, broadband industry practices, data privacy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Access and pricing issues for plasma derived products; Orphan Drug Act and therapies for rare diseases. H.R. 1, One Big Beautiful Bill Act implementation, issues related to biopharmaceutical issues. Prescription drug pricing issues, particularly related to MFN. Medicare Part B provisions relating to home infusion of IVIG.
Issues related to pharmaceutical tariffs and related trade agreements.
Matters related to access of plasma derived products, FDA drug approval and monitoring agency changes. Matters affecting plasma donation and potential plasma shortages. Pharmacy Benefit Manager reform.
AMGEN, INC. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
General education about federal policies impacting pharmaceutical development, approval, and patient access. 340B, Policies impacting public health preparedness and prevention. Policies impacting Cardiovascular and bone health. Pharmacy benefit manager reform proposals. FDA reform, prescription drug reimportation and new proposals.
Policies impacting disease prevention.
Medicare Part D and Medicare Part B drug reimbursement, policies around MFN drug pricing, Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act" implementation, coverage and access for biosimilars.
NORFOLK SOUTHERN CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
General education about policies impacting the rail industry; outreach to House and Senate related to rail operations. Proposed merger between Norfolk Southern and Union Pacific.
General education about policies impacting the rail industry; outreach to House and Senate related to rail operations. Proposed merger between Norfolk Southern and Union Pacific.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AFFORDABLE HOUSING TAX CREDIT COALITION via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Issues related to low-income housing finance; S. 2296, S. 1071, H.R. 6644; S. 2464; H.R. 5913 - Community Investment and Prosperity Act. 21st Century ROAD to Housing Act; build to rent housing proposals.
Implementation of PL 119-21; proposals to strengthen and expand the Low-Income Housing Tax Credit and Tax-Exempt Housing Bonds. Affordable Housing Credit Improvement Act. Affordable Housing Credit Improvement Act of 2025, H.R. 2725, S. 1515.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
U.S. HEMP ROUNDTABLE via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
HR 7212 To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of cannabinoid hemp products, and for other purposes.
Issues related to provisions in the annual appropriations process that regulate Hemp.
Issues related to regulation of Hemp products. H.R. 7024, Hemp Planting Predictability Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
VEEAM SOFTWARE CORP via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Cybersecurity issues related to data resilience and system backup and availability, and ensuring the integrity of artificial intelligence systems.
Cybersecurity and procurement issues related to data resilience and system backup and availability, and ensuring the integrity of artificial intelligence systems.
Department of Defense Authorization and Appropriations legislation.
SOUTHWESTERN COMPANY via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
State Department Appropriations for international cultural exchange programs.
Issues pertaining to J-Visa exchange visitor programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), White House Office
ROCHESTER TAILORED CLOTHING, INC. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
MAUS & HOFFMAN via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Duties on cotton and wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
HAMILTON SHIRTS, LTD. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
TOM JAMES COMPANY via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Duties on cotton and wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
SUPIMA via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
NEW ENGLAND SHIRT CO via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
W DIAMOND GROUP CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
JOSEPH ABBOUD MANUFACTURING CORP (FKA J.A. APPAREL CORP) via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Duties on wool fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
CENTENE CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Issues related to Medicaid, Medicare Advantage, behavioral health and prior authorization.
Issues related to health insurance and affordability.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BUHLER QUALITY YARNS CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Duties on cotton fabrics; Farm Bill reauthorization and extension; Federal initiatives to support domestic manufacturing. Implementation of the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
THE VANGUARD GROUP, INC. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Mutual fund, ETF, money market mutual fund, securities, and systemic risk issues. H.R. 1033, Retirement Fairness for Charities and Educational Institutions Act of 2025; S.424, Retirement Fairness for Charities and Educational Institutions Act of 2025. H.R. 2441, Improving Disclosure for Investors Act of 2025; HR 3383, Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025; issues related to index funds; issues related to fund proxy voting; issues related to access to investment opportunities; issues related to products and markets. H.R. 3682, Financial Stability Oversight Council Improvement Act of 2025.
General tax issues related to mutual funds. Taxation of long term investments. Taxation of RICs and ETFs; potential negative impacts on markets and customers of proposed withholding tax on dividend payments. Monitor implementation of IRC sec. 530A.
SECURITY TRADERS ASSOCIATION via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Equity market structure, trading, and listing and delisting issues. H.R. 3383, INVEST Act of 2025; securities fraud prevention; Section 31 transaction fees.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
IMPERATIVE EXECUTION, INC. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
SEC and FINRA equity market structure issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
GCOM SOFTWARE LLC D/B/A VOYATEK via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · 2T
Government modernization issues; IRS procurement issues and technology modernization initiatives.
Government modernization issues; IRS procurement issues and technology modernization initiatives.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STANLEY BLACK & DECKER INC via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Imports, exports and foreign markets; general trade issues and related matters including duties and tariffs. Issues related to Foreign Trade Zones and manufacturing in the U.S. Section 232 of the Trade Expansion Act of 1962 and Section 301 of the Trade Act of 1974; actions, exemptions and exclusions.
Manufacturing issues, general; Issues related to workforce development, and increased training and education related to advanced manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REINSURANCE ASSOCIATION OF AMERICA via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
H.R. 643 - Federal Insurance Office Elimination Act. Federal Insurance Office legislation. S.2349, INSURE Act; H.R. 4504, INSURE Act. Legislation to create a federal property insurance or reinsurance program. International insurance legislation. Terrorism Risk Insurance legislation. H.R. 7128, TRIA Program Reauthorization Act of 2026; S.4395, Terrorism Risk Insurance Program Reauthorization Act of 2026.
Appropriations, pre-disaster mitigation, NFIP. Risk transfer legislation. H.R. 8845, Commerce, Justice, Science, and Related Agencies Appropriations bill, 2027, and S. ___ - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027. National Oceanic and Atmospheric Administration.
FIDELITY NATIONAL FINANCIAL via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
H.R. 3206, Protecting Americas Property Rights Act.
Issues related to title insurance, HR 3206 Protecting America's Property Rights Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
FEDERATION OF EXCHANGE ACCOMODATORS, INC. via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Monitor any possible change to IRC 1031 including any impact on qualified intermediaries. Monitor all IRC 1031 tax regulatory issues, and any proposed regulation of qualified intermediaries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
BLOOMBERG LP via WILLIAMS AND JENSEN, PLLC
2026 · second_quarter · Q2
Issues relating to investor access to financial identifiers (including implementation of the Financial Data Transparency Act) and market structure. HR3633, CLARITY Act, tokenization.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
GCOM SOFTWARE LLC D/B/A VOYATEK via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · 1A
Government modernization issues; IRS procurement issues and technology modernization initiatives.
Government modernization issues; IRS procurement issues and technology modernization initiatives.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELL INC via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Information technology legislation; appropriations legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
NORFOLK SOUTHERN CORPORATION via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
General education about policies impacting the rail industry; outreach to House and Senate related to rail operations. Proposed merger between Norfolk Southern and Union Pacific.
General education about policies impacting the rail industry; outreach to House and Senate related to rail operations. Proposed merger between Norfolk Southern and Union Pacific.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AFFORDABLE HOUSING TAX CREDIT COALITION via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Issues related to low-income housing finance; S. 2296, S. 1071, H.R. 6644; S. 2464; H.R. 5913 - Community Investment and Prosperity Act. 21st Century Road to Housing Act; build to rent housing proposals.
Implementation of PL 119-21; proposals to strengthen and expand the Low-Income Housing Tax Credit and Tax-Exempt Housing Bonds. Affordable Housing Credit Improvement Act. Affordable Housing Credit Improvement Act of 2025, H.R. 2725, S. 1515.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZOETIS via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Animal health, issues impacting medicines and vaccines for animals.
Issues related to general corporate taxation; and implementation of PL 119-21.
General agricultural issues important to livestock producers, animal health and related policy issues. Issues impacting medicines and vaccines for animals.
VISA via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. Issues relating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 / S.1582 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act. P.L. 119-60. 21st Century Road to Housing Act.
Cybersecurity and information sharing and cyber threats.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI, U.S. via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Monitor general tax issues related to international tax, vaccine excise taxes and orphan drug tax issues; implementation of PL 119-21.
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. 340B, Vaccine issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Support for obesity drug coverage and access.
Treat and Reduce Obesity Act; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169) implementation. Pharmacy benefit manager reform proposals. H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.
Medication affordability and access; general diabetes prevention, 340B, monitoring FDA reform, changes and new programs.
SYNEOS HEALTH, INC. via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Business and corporate tax issues, international tax reform; including international minimum tax proposals; issues related to research and development.
Remote clinical trials, biomedical research & development.
Clinical trials and research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Policies impacting post pandemic public health emergency Covid-19 vaccine reimbursement and distribution. Support for immunization access, access to migraine screening. Support for tick-borne disease research and womens health.
General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; drug importation; and drug shortages. Drug pricing proposals. The 340B program. Pharmacy benefit manager reform proposals, issues related to headache and migraine. P.L. 119-21.
Issues related to pharmaceutical manufacturing and development.
ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
FY 2027 Appropriations.
Issues related to access to home medical equipment and related reimbursement (i.e., the "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4307) and the "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, the "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels. Issues related to continuous glucose monitors.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
NEWS MEDIA ALLIANCE via WILLIAMS AND JENSEN, PLLC
2026 · first_quarter · Q1
Digital news content and publishing; antitrust issues impacting digital news publishers. Artificial Intelligence policies.
Digital news content and publishing; antitrust issues impacting digital news publishers. Artificial Intelligence policies.
Digital news content and publishing; antitrust issues impacting digital news publishers. Artificial Intelligence policies.
Medicare payment issues and Medicaid issues. Medicare Part D. Drug pricing proposals. Protecting Seniors Through Immunization Act. Pharmacy benefit manager reform proposals. Issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN. P.L. 119-21.
General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; drug importation; and drug shortages. Drug pricing proposals. The 340B program. Pharmacy benefit manager reform proposals, issues related to headache and migraine. P.L. 119-21. Legislation and issues related to prior authorization. Issues related to TrumpRX.
Issues related to pharmaceutical manufacturing and development, trade and tariffs; potential tariff actions under Section 232 of the Trade Act of 1962. Issues related to China WRT the BINSA Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Educate policymakers on competition and transparency issues related to artificial intelligence.
Digital news content and publishing; antitrust issues impacting digital news publishers. Artificial Intelligence policies. Stealth Bot Prohibition Act (H.R. 9915).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Accelerated approval pathway; support for Alzheimer's diagnostics; obesity treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Drug pricing policies, implementation of IRA drug pricing policies, access and coverage, most-favored nation drug pricing policies, ORPHAN Cures Act implementation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security.
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy; deduction of ordinary and necessary business expenses.
Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. S. 1582.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act, monitoring efforts around direct-to-consumer policies.
Monitoring 232 investigations, monitoring tariffs, most favored nation drug pricing policies, pharmaceutical IP issues, issues related to China WRT the BINSA bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Department of Defense Authorization and Appropriations legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
Drug pricing policies, implementation of IRA drug pricing policies, access and coverage, most-favored nation drug pricing policies, ORPHAN Cures Act implementation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Financial data privacy; cyber security, cyber insurance, data breach legislation. Credit risk transfer. S.3772, Export-Import Bank Reauthorization Act of 2026; H.R.__ Discussion Draft Export-Import Bank Reauthorization Act of 2026.
H.R. 643 - Federal Insurance Office Elimination Act. Federal Insurance Office legislation. S.2349, INSURE Act; H.R. 4504, INSURE Act. Legislation to create a federal property insurance or reinsurance program. International insurance legislation. Terrorism Risk Insurance legislation. H.R. 7128, TRIA Program Reauthorization Act of 2026; S.4395, Terrorism Risk Insurance Program Reauthorization Act of 2026.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Issues related to general corporate taxation; and implementation of PL 119-21.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Medication affordability and access; general diabetes prevention, 340B, monitoring FDA reform, changes and new programs. SAFE Drugs Act (HR6509/S3794).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Tax issues affecting the pharmaceutical industry including international tax; implementation of PL 119-21. Vaccine excise tax issues and VICP.
Issues related to pharmaceutical manufacturing and development.
Support for immunization access, access to migraine screening. Support for tick-borne disease research and womens health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Educate policymakers on competition and transparency issues related to artificial intelligence.
Digital news content and publishing; antitrust issues impacting digital news publishers. Artificial Intelligence policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies. SAFE Drugs Act (HR6509/S3794).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B Reform, FDA drug approvals, monitoring Food is Medicine initiatives, importation of biopharmaceutical products, pharmaceutical supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy. H.R. 2353. P.L. 119-37; aviation issues impacted by government shutdown.
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security.
Issues related to commercial airline industry policy, aviation security and infrastructure, Aviation taxes, PFC, issues affecting trade in large civil aircraft, and/or tariffs, Real ID provisions pertaining to commercial aviation, aviation security. Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; issues related to payment card security; issues relating to Data Use and Privacy; deduction of ordinary and necessary business expenses.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act, monitoring efforts around direct-to-consumer policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Cybersecurity issues related to data resilience and system backup and availability, and ensuring the integrity of artificial intelligence systems.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Retirement and savings issues, generally. Monitor implementation of IRC sec. 530A.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
Financial data privacy; cyber security, cyber insurance, data breach legislation. Credit risk transfer. S.3772, Export-Import Bank Reauthorization Act of 2026; H.R.__ Discussion Draft Export-Import Bank Reauthorization Act of 2026.
National Flood Insurance Act legislation.
National Oceanic and Atmospheric Administration.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Monitor trade issues including those under section 301 of the Trade Act of 1974, USMCA. Monitor trade issues and supply chain issues related to veterinary pharmaceuticals and active ingredients. Potential tariff actions under Section 232 of the Trade Act of 1962.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
General issues related to patent protections.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to pharmaceutical manufacturing and development, trade and tariffs; potential tariff actions under Section 232 of the Trade Act of 1962.
Tax issues affecting the pharmaceutical industry including international tax; implementation of PL 119-21. Vaccine excise tax issues and VICP.
Medicare payment issues and Medicaid issues. Medicare Part D. Drug pricing proposals. Protecting Seniors Through Immunization Act. Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN. P.L. 119-21.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Educate policymakers on competition and transparency issues related to artificial intelligence.
Digital news content and publishing; antitrust issues impacting digital news publishers. Artificial Intelligence policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE